SI
SRPT icon

Sofinnova Investments’s Sarepta Therapeutics SRPT Stock Holding History

Sofinnova Investments’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-327,618
Closed -$20.9M – 78
2025
Q1 		$20.9M Sell
327,618
-101,153
-24% -$10.6M 1.37% 26
2024
Q4 		$52.1M Buy
+428,771
New +$52.5M 3.8% 6
2024
Q3 		– Sell
-195,852
Closed -$30.9M – 86
2024
Q2 		$30.9M Sell
195,852
-31,636
-14% -$4.06M 1.61% 22
2024
Q1 		$29.5M Buy
+227,488
New +$27.9M 1.64% 25
2023
Q2 		– Sell
-119,065
Closed -$16.4M – 62
2023
Q1 		$16.4M Sell
119,065
-128,890
-52% -$16.7M 1.05% 25
2022
Q4 		$32.1M Buy
247,955
+106,515
+75% +$12.3M 1.91% 14
2022
Q3 		$15.6M Buy
141,440
+10,195
+8% +$1.03M 0.91% 23
2022
Q2 		$9.84M Buy
131,245
+42,365
+48% +$3.12M 0.82% 28
2022
Q1 		$6.94M Sell
88,880
-31,852
-26% -$2.44M 0.53% 42
2021
Q4 		$10.9M Sell
120,732
-36,547
-23% -$3.12M 0.64% 41
2021
Q3 		$14.5M Sell
157,279
-141,221
-47% -$10.9M 0.86% 29
2021
Q2 		$23.2M Buy
+298,500
New +$22.6M 1.34% 18
2021
Q1 		– Sell
-51,848
Closed -$8.84M – 75
2020
Q4 		$8.84M Buy
+51,848
New +$7.68M 0.53% 37
2020
Q2 		– Sell
-101,603
Closed -$9.94M – 89
2020
Q1 		$9.94M Buy
101,603
+13,785
+16% +$1.58M 0.92% 23
2019
Q4 		$11.3M Sell
87,818
-18,596
-17% -$1.88M 0.82% 27
2019
Q3 		$8.02M Buy
+106,414
New +$12.6M 0.72% 31
2019
Q1 		– Sell
-48,894
Closed -$5.34M – 73
2018
Q4 		$5.34M Buy
48,894
+18,979
+63% +$2.37M 0.66% 31
2018
Q3 		$4.83M Sell
29,915
-18,485
-38% -$2.53M 0.43% 39
2018
Q2 		$6.4M Buy
+48,400
New +$4.56M 0.72% 28

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Sofinnova Investments's SRPT Position: Q2 2025 in Review

Sofinnova Investments sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 327,618 shares — an estimated $20.9M sold.

Sofinnova Investments first reported a position in SRPT in Q2 2018 and held it in 19 quarters. The position peaked at $52.1M in Q4 2024. 362 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

  • Sofinnova Investments reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Sofinnova Investments sold 327,618 Sarepta Therapeutics shares in Q2 2025, an estimated $20.9M.
  • Sofinnova Investments first reported a position in Sarepta Therapeutics in Q2 2018 and held it in 19 quarters.
  • Sofinnova Investments's Sarepta Therapeutics position peaked at $52.1M in Q4 2024.
  • 362 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on Sofinnova Investments's 13F filing for Q2 2025, filed 14 Aug 2025.